Skip to main content
. 2020 May 27;38(22):2530–2542. doi: 10.1200/JCO.19.03158

FIG 3.

FIG 3.

Mean change in baseline scores of patient-reported symptom severity. Mean change in baseline score through cycle 13 for (A) fatigue, (B) constipation, (C) diarrhea, (D) nausea/vomiting, (E) peripheral neuropathy, (F) sore mouth, (G) coughing, (H) chest pain, and (I) dyspnea. ABCP, atezolizumab plus bevacizumab, carboplatin, and paclitaxel; ACP, atezolizumab, carboplatin, and paclitaxel; BCP, bevacizumab, carboplatin, and paclitaxel.